Results 21 to 30 of about 547,234 (309)

Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy

open access: yesJournal of Immunology Research, 2023
Background. Systemic inflammation may be involved in the entire cancer process as a promoter and is associated with antitumor immunity. The systemic immune-inflammation index (SII) has been shown to be a promising prognostic factor.
Jun Yang   +9 more
doaj   +1 more source

Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma. [PDF]

open access: yes, 2013
Introduction. Patients with high-grade sarcoma (HGS) frequently develop metastatic disease thus limiting their long-term survival. Lung metastases (LM) have historically been treated with surgical resection (metastasectomy).
Agazaryan, Nzhde   +9 more
core   +2 more sources

A 2009 survey of the Australasian clinical medical physics and biomedical engineering workforce [PDF]

open access: yes, 2010
A survey of the Australasian clinical medical physics and biomedical engineering workforce was carried out in 2009 following on from a similar survey in 2006.
Round, W. Howell
core   +2 more sources

Residency Match Trends, Racial Disparity, and Matching Amid a Pandemic

open access: yesAdvances in Radiation Oncology, 2021
Purpose: Radiation oncology has been facing an evolving crisis in recruitment for several years, and the events of 2020 to 2021 will certainly add to that crisis with the urgency of addressing systemic racial injustice amid a global pandemic. The purpose
April Vassantachart, MD   +3 more
doaj   +1 more source

Radiation oncology in Canada [PDF]

open access: yesJapanese Journal of Clinical Oncology, 2017
In this article we provide an overview of the Canadian healthcare system and the cancer care system in Canada as it pertains to the governance, funding and delivery of radiotherapy programmes. We also review the training and practice for radiation oncologists, medical physicists and radiation therapists in Canada.
Meredith, Giuliani, Mary, Gospodarowicz
openaire   +2 more sources

Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy

open access: yesBMC Urology, 2017
Background Our aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT).
Daniel N. Cagney   +9 more
doaj   +1 more source

Advanced Glycation End Products’ Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

open access: yesGenetics Research, 2023
Background. Advanced glycation end products’ receptor (AGER) is a multiligand receptor that interacts with a wide range of ligands. Previous studies have shown that abnormal AGER expression is closely related to immune infiltration and tumorigenesis ...
Jun Yang   +10 more
doaj   +1 more source

Nanotechnology in Radiation Oncology

open access: yesHematology/Oncology Clinics of North America, 2019
Nanotechnology has made remarkable contributions to clinical oncology. Nanotherapeutics and diagnostic tools have distinctive characteristics which allow them superior abilities to deliver therapeutics and imaging agents for radiation oncology. Compared to solid biopsies and imaging, the analysis of circulating tumor cells (CTCs) offers a more rapid ...
Bo, Sun   +3 more
openaire   +3 more sources

A survey of the Australasian clinical medical physics and biomedical engineering workforce [PDF]

open access: yes, 2007
A survey of the medical physics and biomedical engineering workforce was carried out in 2006. 495 positions(equivalent to 478 equivalent full time (EFT) positions) were captured by the survey.
Round, W. Howell
core   +2 more sources

Does HCC Etiology Impact the Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma? An Asian Liver Radiation Therapy Group Study

open access: yesJournal of Hepatocellular Carcinoma, 2022
Nalee Kim,1,* Jason Chia-Hsien Cheng,2,* Nitin Ohri,3 Wen-Yen Huang,4 Tomoki Kimura,5 Zhao Chong Zeng,6 Victor Ho Fun Lee,7 Chul Seung Kay,8 Jinsil Seong9 1Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan School of Medicine,
Kim N   +8 more
doaj  

Home - About - Disclaimer - Privacy